37 related articles for article (PubMed ID: 3265957)
1. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
[TBL] [Abstract][Full Text] [Related]
2. Anticentromere antibodies in subjects with no apparent connective tissue disease.
Lee SL; Tsay GJ; Tsai RT
Ann Rheum Dis; 1993 Aug; 52(8):586-9. PubMed ID: 8215621
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlation of anticentromere antibodies.
Zuber M; Gotzen R; Filler I
Clin Rheumatol; 1994 Sep; 13(3):427-32. PubMed ID: 7835004
[TBL] [Abstract][Full Text] [Related]
4. Anticentromere antibody--clinical associations. A study of 44 patients.
Caramaschi P; Biasi D; Manzo T; Carletto A; Poli F; Bambara LM
Rheumatol Int; 1995; 14(6):253-5. PubMed ID: 7597381
[TBL] [Abstract][Full Text] [Related]
5. Utility of serologic testing in the diagnosis of noninfectious pulmonary disorders.
White RH; Golden JA
Clin Rev Allergy; 1990; 8(2-3):253-75. PubMed ID: 2292098
[No Abstract] [Full Text] [Related]
6. [Anticentromere antibodies and lung disease without skin involvement].
Fernández-Fernández FJ; Sesma P; Facio A; Guerra JL; González-Moraleja J
An Med Interna; 1997 Apr; 14(4):196-8. PubMed ID: 9181818
[TBL] [Abstract][Full Text] [Related]
7. [Progress in clinical tests and the pathophysiological study of collagen diseases--anti-topoisomerase I antibodies and anticentromere antibodies].
Konndo H
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2409-13. PubMed ID: 9922659
[No Abstract] [Full Text] [Related]
8. Anticentromere antibodies: clinical and biological significance.
Fritzler MJ; Ayer LM
J Rheumatol; 1982; 9(4):489-90. PubMed ID: 6982333
[No Abstract] [Full Text] [Related]
9. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
10. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
11. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
12. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
13. Anticentromere antibodies--clinical correlates.
Wade JP; Sack B; Schur PH
J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]